Further supporting the clinical relevance of our findings, acetaldehyde treatment specifically inhibited growth of BRCA2‐deficient human tumors in xenograft models and PARP inhibitor‐resistant BRCA1‐deficient allografted mammary tumors. This evidence concerns the gene BRCA1 and breast cancer.